SWM
ANAB icon

Spire Wealth Management’s AnaptysBio ANAB Stock Holding History

Spire Wealth Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$81K Buy
1,200
+800
+200% +$48.5K ﹤0.01% 1038
2026
Q1 		$22.2K Buy
+400
New +$21.5K ﹤0.01% 1390
2022
Q4 		– Sell
-130
Closed -$3K – 2302
2022
Q3 		$3K Hold
130
– – ﹤0.01% 1845
2022
Q2 		$3K Hold
130
– – ﹤0.01% 2242
2022
Q1 		$3K Hold
130
– – ﹤0.01% 2312
2021
Q4 		$5K Buy
+130
New +$4.12K ﹤0.01% 2545

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Spire Wealth Management's ANAB Position: Q2 2026 in Review

Spire Wealth Management increased its AnaptysBio (ANAB) stake by 200% in Q2 2026, buying an estimated $48.5K and bringing the position to 1,200 shares worth $81K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Spire Wealth Management first reported a position in ANAB in Q4 2021 and has held it in 6 quarters since. 214 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Spire Wealth Management held 1,200 shares of AnaptysBio worth $81K as of Q2 2026.
  • Spire Wealth Management bought 800 AnaptysBio shares in Q2 2026, an estimated $48.5K.
  • AnaptysBio made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1038 holding.
  • Spire Wealth Management first reported a position in AnaptysBio in Q4 2021 and has held it in 6 quarters since.
  • 214 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.